X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-04 | ALEC | Grasso Marc | CFO | S - Sale | $6.92 | -5,716 | 144,957 | -4% | -$39,562 | ||||||
2024-03-04 | ALEC | Rosenthal Arnon | CEO | S - Sale | $6.92 | -18,837 | 5,930,755 | 0% | -$130,386 | ||||||
2024-03-04 | ALEC | Romano Gary | Chief Medical Officer | S - Sale | $6.92 | -6,001 | 196,313 | -3% | -$41,554 | ||||||
2024-03-04 | ALEC | Kenkare-Mitra Sara | Pres, Head of R, D | S - Sale | $6.92 | -10,169 | 318,847 | -3% | -$70,387 | ||||||
2023-12-04 | ALEC | Grasso Marc | CFO | S - Sale | $5.56 | -4,574 | 150,673 | -3% | -$25,431 | ||||||
2023-12-04 | ALEC | Romano Gary | Chief Medical Officer | S - Sale | $5.56 | -5,035 | 202,314 | -2% | -$27,995 | ||||||
2023-12-04 | ALEC | Rosenthal Arnon | CEO | S - Sale | $5.56 | -23,831 | 5,949,592 | 0% | -$132,500 | ||||||
2023-12-04 | ALEC | Kenkare-Mitra Sara | Pres, Head of R, D | S - Sale | $5.56 | -12,519 | 329,016 | -4% | -$69,606 | ||||||
2023-09-11 | ALEC | Polaris Venture Management Co. Vi, L.L.C. | 10% | S - Sale | $6.00 | -500,000 | 10,853,817 | -4% | -$3,000,000 | ||||||
2023-09-11 | ALEC | McGuire Terrance | Dir, 10% | S - Sale | $6.00 | -500,000 | 10,948,212 | -4% | -$3,000,000 | ||||||
2023-09-05 | ALEC | Rosenthal Arnon | CEO | S - Sale | $5.19 | -5,647 | 5,575,823 | 0% | -$29,333 | ||||||
2023-09-05 | ALEC | Kenkare-Mitra Sara | Pres, Head of R, D | S - Sale | $5.19 | -6,214 | 177,935 | -3% | -$32,277 | ||||||
2023-09-05 | ALEC | Romano Gary | Chief Medical Officer | S - Sale | $5.19 | -2,771 | 99,349 | -3% | -$14,393 | ||||||
2023-09-05 | ALEC | Grasso Marc | CFO | S - Sale | $5.19 | -1,114 | 32,247 | -3% | -$5,786 | ||||||
2023-06-02 | ALEC | Kenkare-Mitra Sara | Pres, Head of R, D | S - Sale | $6.90 | -4,092 | 184,149 | -2% | -$28,250 | ||||||
2023-06-02 | ALEC | Grasso Marc | CFO | S - Sale | $6.90 | -1,050 | 33,361 | -3% | -$7,249 | ||||||
2023-06-02 | ALEC | Romano Gary | Chief Medical Officer | S - Sale | $6.90 | -2,617 | 102,120 | -2% | -$18,067 | ||||||
2023-06-02 | ALEC | Rosenthal Arnon | CEO | S - Sale | $6.90 | -5,255 | 5,581,470 | 0% | -$36,279 | ||||||
2023-03-17 | ALEC | Rosenthal Arnon | CEO | S - Sale | $6.22 | -15,186 | 5,586,725 | 0% | -$94,428 | ||||||
| M | 2022-12-02 | ALEC | Romano Gary | Chief Medical Officer | S - Sale | $8.47 | -5,383 | 104,737 | -5% | -$45,612 | |||||
2023-03-02 | ALEC | Kenkare-Mitra Sara | Pres, Head of R, D | S - Sale | $8.32 | -10,124 | 188,241 | -5% | -$84,216 | ||||||
2023-03-02 | ALEC | Grasso Marc | CFO | S - Sale | $8.32 | -1,291 | 34,411 | -4% | -$10,739 | ||||||
2023-03-02 | ALEC | Rosenthal Arnon | CEO | S - Sale | $8.32 | -5,849 | 5,558,921 | 0% | -$48,651 | ||||||
2022-09-02 | ALEC | Romano Gary | Chief Medical Officer | S - Sale | $10.62 | -2,177 | 90,073 | -2% | -$23,120 | ||||||
2022-09-02 | ALEC | King Robert | Chief Development Officer | S - Sale | $10.62 | -176 | 529,295 | 0% | -$1,869 | ||||||
2022-06-02 | ALEC | King Robert | Chief Development Officer | S - Sale | $8.71 | -177 | 529,471 | 0% | -$1,542 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |